ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of 400 μg Twice Daily of Aclidinium Bromide vs. Placebo When Administered to Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01636401
Recruitment Status : Completed
First Posted : July 10, 2012
Last Update Posted : August 21, 2013
Sponsor:
Information provided by (Responsible Party):
Daewoong Pharmaceutical Co. LTD.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2013
  Actual Study Completion Date : May 2013